manufacturing

R&D

The field of regenerative medicine is advancing rapidly, offering transformative solutions for a wide range of health conditions.

News

The EU has proposed legislation to safeguard the supply of critical medicines but pharma and patient groups are concerned about the details.

News

MSD has opened the doors of a $1bn facility at its site in Durham, North Carolina, that will be used to produce its HPV vaccine Gardasil.

News

Trump threatened tariffs if businesses do not reshore production to the US - and Lilly has now revealed a $27bn spend on new domestic facilities.

News

The FDA has said there is no longer a shortage in the US market for Novo Nordisk's GLP-1 agonist semaglutide, ending sales of compounded forms.

News

It's been reported that the UK government made an offer of £78 million in funding for AstraZeneca's abandoned £450 million vaccine facility in Speke.